References

  1. SYNTHROID [package insert]. North Chicago, IL: AbbVie Inc.
  2. Data on file. IQVIA Top Branded Oral Rx Medication. AbbVie Inc. January 2025.
  3. Lomenick JP, Wang L, Ampah SB, Saville BR, Greenwald Fl. Generic levothyroxine compared with SYNTHROID in young children with congenital hypothyroidism. J Clin Endocrinol Metab. 2013;98(2):653-658. doi:10.1210/jc.2012-3558
  4. Q&A on CGMP requirements. Food & Drug Administration. Accessed September 30, 2022.
    https://www.fda.gov/drugs/pharmaceutical-quality-resources/qa-cgmp-requirements
  5. Current Good Manufacturing (CGMP) Regulations. Food & Drug Administration. Accessed September 30, 2022. https://www.fda.gov/drugs/pharmaceutical-quality-resources/current-good-manufacturing-practice-cgmp-regulations
  6. Data on file. SYNTHROID Patient AAU Mistaken User Analysis AbbVie Inc. April 2021.
  7. Data on file. Protection Tile Language Spreadsheet Update. January 2024.
  8. Data on file. Synthroid Rx Analyst Pharmacy Audit. AbbVie Inc. January 2024.
  9. US Food & Drug Administration. Approved Drug Products with Therapeutic Equivalence Evaluations. 44th ed. US Food & Drug Administration, Center for Drug Evaluation and Research. Published 2024. Accessed July 31, 2024. https://www.fda.gov/media/71474/download
  10. Baskin HJ, Cobin RH, Duick DS, et al; for American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract. 2002;8(6):457-469.
  11. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988-1028. doi:10.4158/EP12280.GL
  12. Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-1751 doi:10.1089/thy.2014.0028
  13. Managed Markets Insight and Technology, LLCTM a trademark of MMIT, as of 10/09/2024.
  14. Data on file. IQVIA Data and Analytics. AbbVie Inc. January 2023.
  15. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160:526-534. doi:10.1001/archinte.160.4.526
  16. Bianco AC, Bao Y, Antunez Flores O, et al. Levothyroxine treatment adequacy and formulation changes in patients with hypothyroidism: a retrospective study of real-world data from the United States. Thyroid. 2023;33(8):940-949. doi:10.1089/thy.2022.0382
  17. Carr D, McLeod DT, Parry G, Thornes HM. Fine adjustment of thyroxine replacement dosage: comparison of the thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment. Clin Endocrinol (Oxf). 1988;28(3):325-333. doi:10.1111/j.1365-2265.1988.tb01219.x
  18. Demers LM, Spencer CA. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Clin Endocrinal (Oxf). 2003;58(2):138-140. doi:10.1046/j.1365-2265.2003.01681.x
  19. Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2017;27(3):315-389. doi:10.1089/thy.2016.0457
  20. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-499. doi:10.1210/jcem.87.2.8182